نتایج جستجو برای: t cell inhibitor

تعداد نتایج: 2296471  

Journal: :iranian biomedical journal 0
پریسا موسوی شفاعی parisa mousavi-shafaei عبدعلی ضیایی abed-ali ziaee uwe zangemeister-wittke

background: malignant melanoma is a highly metastatic cutaneous cancer and typically refractory to chemotherapy. deregulated apoptosis has been identified as a major cause of cancer drug resistance, and upregulated expression of the inhibitor of apoptosis protein melanom, an inhibitor of apoptosis (ml-iap) is frequent in melanoma. methods: based on the conclusion that ml-iap expression contribu...

Indoleamine 2,3-dioxygenase (IDO), an enzyme involved in the catabolism of tryptophan, is expressed by a variety of cells and tissues such as macrophages, dendritic cells, cells of the endocrine system and by the placenta. IFN- γ is the main inducer of this enzyme. IDO acts as an important defense mechanism of innate immunity against pathogens. It also has tumor suppressive activity and prolong...

Journal: :Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2017
Hong-Hui Yang Yan Chen Chuan-Yu Gao Zhen-Tian Cui Jian-Min Yao

OBJECTIVE This study explored the protective effects of the microRNA-126 (miR-126)-mediated PI3K/Akt/eNOS signaling pathway on human cardiac microvascular endothelial cells (HCMECs) against hypoxia/reoxygenation (H/R)-induced injury and the inflammatory response. METHODS Untreated HCMECs were selected for the control group. After H/R treatment and cell transfection, the HCMECs were assigned t...

Journal: :Journal of Investigative Dermatology 2022

The chemokine receptor CCR4 mediates CCL17- and CCL22-driven chemotaxis of Th2 cells into the skin patients with atopic dermatitis (AD). RPT193 is an oral inhibitor that has been developed to treat AD other allergic inflammatory diseases. safety efficacy as monotherapy for moderate-to-severe was previously described in a placebo-controlled, double-blinded Phase 1 study. Here, we present periphe...

2016
Nameeta P. Richard Raffaella Pippa Megan M. Cleary Alka Puri Deanne Tibbitts Shawn Mahmood Dale J. Christensen Sophia Jeng Shannon McWeeney A. Thomas Look Bill H. Chang Jeffrey W. Tyner Michael P. Vitek María D. Odero Rosalie Sears Anupriya Agarwal

Recent evidence suggests that inhibition of protein phosphatase 2A (PP2A) tumor suppressor activity via the SET oncoprotein contributes to the pathogenesis of various cancers. Here we demonstrate that both SET and c-MYC expression are frequently elevated in T-ALL cell lines and primary samples compared to healthy T cells. Treatment of T-ALL cells with the SET antagonist OP449 restored the activ...

Journal: :Plant physiology 1991
H J Meyer J van Staden

The level of an inhibitor of tissue-type plasminogen activator (t-PA) increased slowly during the early developmental stage of seeds of Erythrina caffra Thunb. Thereafter, the inhibitor increased exponentially until the seeds reached maturity. At maturity, the t-PA inhibitor levels in the cotyledons were 38 times higher than the levels at the onset of seed development. The t-PA inhibitor accumu...

Journal: :Journal of leukocyte biology 1998
A Roos E J Schilder-Tol J J Weening J Aten

CD134 (OX40) is involved in T cell costimulation and T cell-dependent antibody production. We show strongly increased T cell expression of CD134 in a model of T helper 2-mediated systemic autoimmunity, induced by HgCl2. Regulation of CD134 expression on CD4+ T cells was further studied in vitro, identifying CD134 as an early marker of T cell activation. CD134 expression could be induced by inte...

Journal: :Blood 1988
J J Emeis C J Edgell

The fibrinolytic characteristics of the endothelial hybrid cell line EA.hy 926, established by fusing a human umbilical vein endothelial cell with a human carcinoma cell line, were studied. The hybrid cell line produced large amounts of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor type 1, and a small amount of urokinase. All plasminogen activator present in conditio...

Journal: :Cancer Cell International 2021

Abstract Background T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with a high risk of induction failure and poor outcomes, relapse due to drug resistance. Recent studies show that bromodomains extra-terminal (BET) protein inhibitors are promising anti-cancer agents. ARV-825, comprising BET inhibitor conjugated cereblon ligand, was recently developed attenuate the growth m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید